HomeCompareNPRRF vs SBUX

NPRRF vs SBUX: Dividend Comparison 2026

NPRRF yields 1.90% · SBUX yields 2.84%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SBUX wins by $144.6K in total portfolio value
10 years
NPRRF
NPRRF
● Live price
1.90%
Share price
$9.96
Annual div
$0.19
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.5K
Annual income
$214.67
Full NPRRF calculator →
SBUX
SBUX
● Live price
2.84%
Share price
$86.72
Annual div
$2.46
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$167.0K
Annual income
$71,136.45
Full SBUX calculator →

Portfolio growth — NPRRF vs SBUX

📍 SBUX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNPRRFSBUX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NPRRF + SBUX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NPRRF pays
SBUX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NPRRF
Annual income on $10K today (after 15% tax)
$161.38/yr
After 10yr DRIP, annual income (after tax)
$182.47/yr
SBUX
Annual income on $10K today (after 15% tax)
$241.12/yr
After 10yr DRIP, annual income (after tax)
$60,465.98/yr
At 15% tax rate, SBUX beats the other by $60,283.51/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NPRRF + SBUX for your $10,000?

NPRRF: 50%SBUX: 50%
100% SBUX50/50100% NPRRF
Portfolio after 10yr
$94.7K
Annual income
$35,675.57/yr
Blended yield
37.66%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

NPRRF
No analyst data
SBUX
Analyst Ratings
28
Buy
27
Hold
3
Sell
Consensus: Buy
Price Target
$104.00
+19.9% upside vs current
Range: $90.00 — $120.00
Altman Z
2.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NPRRF buys
0
SBUX buys
0
No recent congressional trades found for NPRRF or SBUX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNPRRFSBUX
Forward yield1.90%2.84%
Annual dividend / share$0.19$2.46
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%48.3%
Portfolio after 10y$22.5K$167.0K
Annual income after 10y$214.67$71,136.45
Total dividends collected$2.0K$136.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: NPRRF vs SBUX ($10,000, DRIP)

YearNPRRF PortfolioNPRRF Income/yrSBUX PortfolioSBUX Income/yrGap
1← crossover$10,890$189.86$11,121$420.68$231.00SBUX
2$11,845$193.23$12,548$648.40$703.00SBUX
3$12,871$196.43$14,440$1,013.98$1.6KSBUX
4$13,971$199.48$17,068$1,617.30$3.1KSBUX
5$15,152$202.37$20,912$2,649.52$5.8KSBUX
6$16,418$205.11$26,875$4,499.29$10.5KSBUX
7$17,774$207.70$36,771$8,014.12$19.0KSBUX
8$19,229$210.16$54,542$15,197.11$35.3KSBUX
9$20,787$212.48$89,602$31,242.49$68.8KSBUX
10$22,457$214.67$167,011$71,136.45$144.6KSBUX

NPRRF vs SBUX: Complete Analysis 2026

NPRRFStock

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. The company's Medical Device business develops, manufactures, and sells medical equipment for injection-infusion and dialysis treatment, and products related to diabetes and cell cultures, as well as the sale of artificial organ-related products. Its Pharmaceutical business provides pharmaceutical combination products, including dual chamber bags, pre-filled syringes, and half-type kits; and contract manufacturing services for orally administered drugs, injectables, and external preparations, as well as logistic and distribution services. The company's Pharma Packaging business offers glass products and other comprehensive pharmaceutical packaging, such as glass vials, ampoules, syringes, and cartridges; glass tubes; glass bulbs for vacuum flasks; and other parts of pharmaceutical packaging, such as rubber plugs. Its Other business provides thermostable enzymes for clinical chemistry. The company also offers business management services. Nipro Corporation serves customers in Japan, the Americas, Europe, and rest of Asia. The company was founded in 1947 and is headquartered in Osaka, Japan.

Full NPRRF Calculator →

SBUXConsumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →
📬

Get this NPRRF vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NPRRF vs SCHDNPRRF vs JEPINPRRF vs ONPRRF vs KONPRRF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.